The 3rd World Parkinson Congress includes three days of sessions discussing the latest in Parkinson’s science and care. PDF’s reporters are listening in and reporting back to let you know what they have seen and heard. In particular, PDF Research Advocates Kim and Libbe Erickson of Stillwater, MN, were busy yesterday reporting on three sessions – covering treatments such as levodopa, the search for biomarkers and updates on deep brain stimulation. Here are their reports:
From Linda Morgan, M.B.A., R.Ph., member People with Parkinson’s Advisory Council I arrived early in Montreal for the 3rd World Parkinson Congress, which will officially start on Tuesday. I came in early to be part of an ‘historic’ dinner and meeting between researchers from the Parkinson Study Group (PSG) and those of us involved with Parkinson’s Advocates in Research (PAIR).
The 2nd World Parkinson Congress includes three days of sessions discussing the latest news in Parkinson’s science and care. PDF’s reporters have been listening in during this first day and a half. We have asked them to let us know what they have seen and heard….and to share the most important messages they are hearing as people living with Parkinson’s. Here are two reports from Wednesday, September 29: Steve DeWitteSession Attended: Early Diagnosis and PD “This session included four presentations. In the second, Andrew Siderowf, M.D., presented results from trials studying olfaction, or sense of smell. He and other colleagues… Read More